apg-1252
Showing 1 - 5 of 5
EGFR Positive NSCLC Trial in China (APG-1252, Osimertinib Mesylate Tablets)
Recruiting
- EGFR Positive Non-small Cell Lung Cancer
- APG-1252
- Osimertinib Mesylate Tablets
-
Guangzhou, Guangdong, China
- +3 more
Oct 27, 2021
Small Cell Lung Cancer and Other Solid Tumors Trial in Guangzhou (APG-1252)
Terminated
- Small Cell Lung Cancer and Other Solid Tumors
- APG-1252
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Aug 24, 2021